Did You Know?

Editor’s Picks

Latest News

Jaguar Health Subsidiary Napo Pharmaceuticals Initiates Pivotal Phase 3 Clinical Trial of Crofelemer (Mytesi) for Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy

A Significant Proportion of Patients Receiving Targeted Cancer Therapy Experience Diarrhea Initial Tranche of Non-dilutive Financing Transaction Increased from $5...

Mobile AI technology from Saykara helps Nephrology Associates of Delaware boost physician productivity and well-being, increase face time with patients

By automating production of clinical notes, the artificially intelligent voice assistant from Saykara reduces computer data entry by physicians and...

FDA Amends Emergency Use Authorization for Hologic’s Aptima SARS-CoV-2 Assay to Include COVID-19 Testing of Asymptomatic Individuals, Symptomatic Sample Pooling

MARLBOROUGH, Mass.--(BUSINESS WIRE)--#COVID19--Hologic, Inc. (Nasdaq: HOLX) announced today that its Aptima® SARS-CoV-2 assay, which initially received Emergency Use Authorization (EUA)...

PQ Bypass Completes Enrollment in DETOUR2 Percutaneous Femoral-Popliteal Bypass Pivotal Study for Patients With Complex Peripheral Arterial Disease

FDA-designated Breakthrough Device now one step closer to PMA submission MILPITAS, Calif.--(BUSINESS WIRE)--#ClinicalTrial--PQ Bypass, an innovative medical device company pioneering...

error: Content is protected !!